Advanced Medicine

8 articles in this category · Last updated May 23, 2026

Advanced Medicine covers the frontier treatments international patients most often travel to China specifically to access: CAR-T cell therapy, proton and heavy-ion radiation, complex neurosurgery and cardiac surgery, precision radiotherapy platforms (TomoTherapy, CyberKnife, Gamma Knife, MR-Linac), and the genomic testing that increasingly drives treatment selection.

The articles in this category answer eligibility questions, pricing questions, and the realistic question of how to evaluate fit before traveling. Every advanced therapy here requires clinical eligibility review before any travel commitment -- this is the category where MedCareInChina's Free Pathway Scan most often pays off, because the gap between "I want this" and "I'm clinically eligible" is real, and the cost of finding out the hard way is high.

Browse the curated reads below, grouped by treatment modality.

Cell therapy and clinical trials

CAR-T cell therapy has six NMPA-approved products in China and operates at scale at multiple hematology centers. Beyond approved products, clinical trial enrollment is the pathway to investigational agents. Both guides below carry honest eligibility frameworks -- including the constraints that determine whether an international patient can actually access these options.

Advanced radiation therapy

China's proton and heavy-ion infrastructure (led by Shanghai Proton & Heavy-Ion Center) and the full precision-radiotherapy landscape (TomoTherapy, CyberKnife, Gamma Knife, MR-Linac) cover the cases where standard photon radiation isn't optimal. Both guides explain which modalities suit which indications and what realistic timelines and costs look like.

Frontier surgery and diagnostics

Complex neurosurgery and cardiac surgery -- where Fuwai alone performs over 14,000 cardiac surgeries annually -- and the genetic testing infrastructure that increasingly drives precision treatment selection. These three guides cover the surgical and diagnostic frontiers where China's volume-driven expertise is most visible.